Liver Diseases  >>  Lenvima (lenvatinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lenvima (lenvatinib) / Eisai, Merck (MSD)
E7080-J081-202, NCT00946153: Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)

Checkmark ILCA 2013
Sep 2013 - Sep 2013: ILCA 2013
Checkmark ASCO-GI 2013
Jan 2013 - Jan 2013: ASCO-GI 2013
Checkmark P1/2 data
More
Completed
1/2
66
Japan, RoW
Lenvatinib, E7080
Eisai Co., Ltd.
Hepatocellular Carcinoma
06/14
08/15

Download Options